he majority of chest wall defects requiring reconstruction are secondary to ablation for primary chest wall tumors, locally invasive breast or lung tumors, and metastatic lesions. 1 Other indications for chest wall reconstruction include trauma, infection, radiation-induced ulceration and necrosis leading to exposed hardware, mediastinitis, bronchopleural fistula, and empyema. 1-3 A recent review of an 81-patient cohort from 2003 to 2014 reported indications for chest wall resection and reconstruction to be primarily oncologic (61 percent of patients), and a minority for desmoid tumors (12 percent), bronchopleural fistula (4 percent), infection (9 percent), and anatomical deformity (9 percent) (Level of Evidence: Therapeutic, IV). 3 A previous study of 200 chest wall resections from 1975 to 2000 similarly highlighted reconstructive indications for primary lung cancer with extension into the chest wall (38 percent of patients), primary chest wall tumors (27 percent), breast
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.